Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model.

Oltrabella F, Melgoza A, Nguyen B, Guo S.

Dev Growth Differ. 2017 May;59(4):194-210. doi: 10.1111/dgd.12351. Epub 2017 May 17. Review.

PMID:
28516445
2.

Parental Substance Abuse As an Early Traumatic Event. Preliminary Findings on Neuropsychological and Personality Functioning in Young Drug Addicts Exposed to Drugs Early.

Parolin M, Simonelli A, Mapelli D, Sacco M, Cristofalo P.

Front Psychol. 2016 Jun 16;7:887. doi: 10.3389/fpsyg.2016.00887. eCollection 2016.

3.

Epigenetic Effects of Cannabis Exposure.

Szutorisz H, Hurd YL.

Biol Psychiatry. 2016 Apr 1;79(7):586-94. doi: 10.1016/j.biopsych.2015.09.014. Epub 2015 Nov 3. Review.

4.

Developmental regulation of fear learning and anxiety behavior by endocannabinoids.

Lee TT, Hill MN, Lee FS.

Genes Brain Behav. 2016 Jan;15(1):108-24. doi: 10.1111/gbb.12253. Epub 2015 Nov 5. Review.

5.

It's not your mother's marijuana: effects on maternal-fetal health and the developing child.

Warner TD, Roussos-Ross D, Behnke M.

Clin Perinatol. 2014 Dec;41(4):877-94. doi: 10.1016/j.clp.2014.08.009. Epub 2014 Sep 27. Review.

6.

Prenatal marijuana exposure predicts marijuana use in young adulthood.

Sonon KE, Richardson GA, Cornelius JR, Kim KH, Day NL.

Neurotoxicol Teratol. 2015 Jan-Feb;47:10-5. doi: 10.1016/j.ntt.2014.11.003. Epub 2014 Nov 13.

7.

Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Ross EJ, Graham DL, Money KM, Stanwood GD.

Neuropsychopharmacology. 2015 Jan;40(1):61-87. doi: 10.1038/npp.2014.147. Epub 2014 Jun 18. Review.

8.

Adverse health effects of marijuana use.

Volkow ND, Baler RD, Compton WM, Weiss SR.

N Engl J Med. 2014 Jun 5;370(23):2219-27. doi: 10.1056/NEJMra1402309. Review. No abstract available.

9.

Neuronal substrates and functional consequences of prenatal cannabis exposure.

Calvigioni D, Hurd YL, Harkany T, Keimpema E.

Eur Child Adolesc Psychiatry. 2014 Oct;23(10):931-41. doi: 10.1007/s00787-014-0550-y. Epub 2014 May 3. Review.

10.

Long-term consequences of perinatal fatty acid amino hydrolase inhibition.

Wu CS, Morgan D, Jew CP, Haskins C, Andrews MJ, Leishman E, Spencer CM, Czyzyk T, Bradshaw H, Mackie K, Lu HC.

Br J Pharmacol. 2014 Mar;171(6):1420-34. doi: 10.1111/bph.12500.

11.

Cannabis and psychosis: Neurobiology.

Shrivastava A, Johnston M, Terpstra K, Bureau Y.

Indian J Psychiatry. 2014 Jan;56(1):8-16. doi: 10.4103/0019-5545.124708. Review.

12.

Maternal lifestyle and environmental risk factors for autism spectrum disorders.

Lyall K, Schmidt RJ, Hertz-Picciotto I.

Int J Epidemiol. 2014 Apr;43(2):443-64. doi: 10.1093/ije/dyt282. Epub 2014 Feb 11. Review.

13.

Food for thought: hormonal, experiential, and neural influences on feeding and obesity.

Karatsoreos IN, Thaler JP, Borgland SL, Champagne FA, Hurd YL, Hill MN.

J Neurosci. 2013 Nov 6;33(45):17610-6. doi: 10.1523/JNEUROSCI.3452-13.2013. Review.

14.

Abnormal screening for gestational diabetes, maternal mood disorder, and preterm birth.

Sit D, Luther J, Dills JL, Eng H, Wisniewski S, Wisner KL.

Bipolar Disord. 2014 May;16(3):308-17. doi: 10.1111/bdi.12129. Epub 2013 Oct 24.

15.

The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis.

Díaz-Alonso J, Aguado T, Wu CS, Palazuelos J, Hofmann C, Garcez P, Guillemot F, Lu HC, Lutz B, Guzmán M, Galve-Roperh I.

J Neurosci. 2012 Nov 21;32(47):16651-65. doi: 10.1523/JNEUROSCI.0681-12.2012.

16.

Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development.

Díaz-Alonso J, Guzmán M, Galve-Roperh I.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3229-41. doi: 10.1098/rstb.2011.0385. Review.

17.

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, Moran JH, Prather PL.

Biochem Pharmacol. 2012 Apr 1;83(7):952-61. doi: 10.1016/j.bcp.2012.01.004. Epub 2012 Jan 18.

18.
19.

Cannabis use and cognitive dysfunction.

Shrivastava A, Johnston M, Tsuang M.

Indian J Psychiatry. 2011 Jul;53(3):187-91. doi: 10.4103/0019-5545.86796. No abstract available.

20.

Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment.

Morris CV, DiNieri JA, Szutorisz H, Hurd YL.

Eur J Neurosci. 2011 Nov;34(10):1574-83. doi: 10.1111/j.1460-9568.2011.07884.x. Review.

Supplemental Content

Support Center